
zzso zzso zzso zzso multiple sclerosis zzso patients, who underwent treatment with zzso zzso zzso zzso zzso zzso and zzso zzso (20 per treatment group), were assessed for levels of zzso zzso factor zzso in the zzso of zzso and zzso peripheral blood zzso cells zzso in the first year of zzso zzso zzso zzso zzso zzso basic protein zzso and zzso were used as zzso zzso responses by zzso and zzso responses were also zzso The zzso zzso patient group showed a progressive increase in zzso levels, from baseline to month zzso thereafter, the levels remained stable and significantly greater compared with baseline and controls zzso zzso zzso had no effect on zzso production, whereas zzso induced a slight decrease zzso zzso analysis revealed a significant decrease of zzso an increase of zzso zzso and zzso in zzso zzso patients, and an increase of zzso in patients treated with zzso zzso and zzso No significant correlation was found between zzso zzso in the zzso of zzso and zzso response, zzso load, and measures of zzso Increased zzso production related to zzso treatment can have implications for understanding the mechanism of action of this zzso agent, in light of evidence suggesting its effects in promoting zzso immunity in zzso zzso however, a clinically measurable effect, especially in terms of an impact on actual disease zzso remains to be zzso 

